产品介绍：
产品说明
包装
10, 50 mg in glass bottle
生化/生理作用
Ibutilide hemifumarate salt is considered a new generation "pure" Class III antiarrhythmic agent. Ibutilide binds to and alters the activity of hERG potassium channels, delayed inward rectifier potassium (IKr) channels and L-type (dihydropyridine sensitive) calcium channels.
特点和优势
This compound was developed by Pfizer. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
This compound is featured on the Potassium Channels page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
基本信息
| 经验(实验)分子式 | C20H36N2O3S · 0.5C4H4O4 |
| 分子量 | 442.61 |
| MDL编号 | MFCD01715410 |
| PubChem化学物质编号 | 329815470 |
| NACRES | NA.77 |
产品性质
| 质量水平 | 100 |
| 测定 | ≥98% (HPLC) |
| 形式 | solid |
| 颜色 | off-white to tan |
| 溶解性 | H2O: >20 mg/mL |
| 创始人 | Pfizer |
| 储存温度 | room temp |
| SMILES string | OC(=O)\C=C\C(O)=O.CCCCCCCN(CC)CCCC(O)c1ccc(NS(C)(=O)=O)cc1.CCCCCCCN(CC)CCCC(O)c2ccc(NS(C)(=O)=O)cc2 |
| InChI | 1S/2C20H36N2O3S.C4H4O4/c2*1-4-6-7-8-9-16-22(5-2)17-10-11-20(23)18-12-14-19(15-13-18)21-26(3,24)25;5-3(6)1-2-4(7)8/h2*12-15,20-21,23H,4-11,16-17H2,1-3H3;1-2H,(H,5,6)(H,7,8)/b;;2-1+ |
| InChI key | PCIOHQNIRPWFMV-WXXKFALUSA-N |
| Gene Information | human ... KCNH2(3757) |
安全信息
| 象形图 |   |
| 警示用语： | Warning |
| 危险声明 | H302 - H361d |
| 预防措施声明 | P202 - P264 - P270 - P280 - P301 + P312 - P308 + P313 |
| 危险分类 | Acute Tox. 4 Oral - Repr. 2 |
| 储存分类代码 | 11 - Combustible Solids |
| WGK | WGK 1 |
| 闪点(F) | Not applicable |
| 闪点(C) | Not applicable |
